VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.1658
-0.0066 (-3.83%)
Apr 10, 2026, 4:00 PM EDT - Market closed
VolitionRx Employees
VolitionRx had 75 employees as of September 30, 2025. The number of employees decreased by 21 or -21.88% compared to the same quarter last year.
Employees
75
Change
-21
Growth
-21.88%
Revenue / Employee
$23,032
Profits / Employee
-$311,427
Market Cap
26.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 75 | -21 | -21.88% | 75 | 0 |
| Jun 30, 2025 | 70 | -31 | -30.69% | 70 | 0 |
| Mar 31, 2025 | 82 | -26 | -24.07% | 82 | 0 |
| Dec 31, 2024 | 85 | -25 | -22.73% | 85 | 0 |
| Sep 30, 2024 | 96 | -18 | -15.79% | 96 | 0 |
| Jun 30, 2024 | 101 | -10 | -9.01% | 101 | 0 |
| Mar 31, 2024 | 108 | 4 | 3.85% | 108 | 0 |
| Dec 31, 2023 | 110 | 6 | 5.77% | 110 | 0 |
| Sep 30, 2023 | 114 | 15 | 15.15% | 114 | 0 |
| Jun 30, 2023 | 111 | 12 | 12.12% | 111 | 0 |
| Dec 31, 2022 | 104 | 21 | 25.30% | 104 | 0 |
| Jun 30, 2022 | 99 | - | - | 99 | 0 |
| Dec 31, 2021 | 83 | 18 | 27.69% | 83 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 713 |
| TELA Bio | 209 |
| Myomo | 195 |
| Cytosorbents | 129 |
| Lifeward | 81 |
| Adagio Medical Holdings | 80 |
| Pulsenmore | 71 |
| IceCure Medical | 69 |
VNRX News
- 10 days ago - VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update - PRNewsWire
- 11 days ago - VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium - PRNewsWire
- 12 days ago - Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients - PRNewsWire
- 16 days ago - Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference - PRNewsWire
- 16 days ago - VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update - PRNewsWire
- 17 days ago - Volition Announces Detection of Over 95% of Early-Stage Cancers - PRNewsWire
- 24 days ago - Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA - PRNewsWire
- 5 weeks ago - Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems - PRNewsWire